Faculty Profile: Ilana Gareen, PhD, University of California, Los Angeles, 1997

Ilana Gareen
Ilana Gareen, PhD, University of California, Los Angeles, 1997
Assistant Professor of Epidemiology (Research)
Epidemiology
Work: 401-863-1758
Dr. Gareen focuses on cancer screening trials. She is interested in the downstream consequences of screening, including medical care utilization, iatrogenic consequences, changes in quality of life, and the impact of screening and screening results on smoking cessation.

Dr. Gareen also focuses on potential biases arising in cancer screening trials.

Biography

Dr. Gareen has a Ph.D. in Epidemiology from U.C.L.A. School of Public Health. She is interested in using epidemiologic methods to evaluate new medical technologies. She currently is working on evaluating lung cancer screening in the National Lung Cancer Screening Trial (NLST). In this trial she is responsible the abstraction of medical records to evaluate the downstream consequences of screening, changes in quality of life associated with screening and screening result, smoking, and assignment of cause of death.

Dr. Gareen co-teaches clinical trials in the Department of Community Health. In the past, she taught Health and Human reproduction. Her dissertation work focused on reproductive epidemiology.

Institutions

Bu

Research Description

Dr. Gareen has been involved with the American College of Radiology Imaging Network (ACRIN) since its inception. As part of ACRIN, she has worked on the National Lung Cancer Screening Trial, the National Colonography Screening Trial, and the National Oncologic PET Registry.

Grants and Awards

Pew Health Policy Fellow 1989-1992

Affiliations

Society for Epidemiologic Research

Funded Research

U01 CA79778 (Gatsonis) 03/02/1999-12/31/2007
NCI
Biostatistics Data Management Center for ACRIN
The American College of Radiology Imaging Network (ACRIN) is a national cooperative group, organized and funded by the National Cancer Institute in 1999 to conduct multi-center, interdisciplinary clinical evaluations of diagnostic imaging in the early detection and diagnosis, staging, and treatment of cancer. ACRIN's ultimate goal is to develop and disseminate scientific knowledge that will help reduce cancer-related mortality and morbidity and improve the quality of life of cancer patients. The Biostatistics and Data Management Center of ACRIN is directed by Constantine Gatsonis and is operated jointly by the Center for Statistical Sciences, Brown University and the American College of Radiology. The main responsibility for data collection and management is with the Philadelphia office of the ACR. The overall direction of the BDMC and the main responsibility for study design, monitoring, and data analysis is with Brown. In addition to his role as Network Statistician of ACRIN, Dr. Gatsonis is the protocol statistician in current ACRIN studies of screening for breast and lung cancer and in a study of diagnostic imaging for cervical cancer.

U01 CA79778 S2 (Gatsonis) 07/01/2002-12/31/2007
NCI
Biostatistics Data Management Center for NLST
This proposal responds to the need for biostatistical support and methodologic leadership in the development and implementation of contemporary screening for the detection of lung cancer.

U01 CA79778 S2 (Gatsonis) 01/01/2005-12/31/2007
NCI
Biostatistics Data Management Center for Computerized Tomographic Colonography Trial
This proposal responds to the need for biostatistical support and methodological leadership to ACRIN investigators in the development and implementation of Protocol 6664.

Selected Publications

  • Park ER,Gareen IF, Adams A, Ostroff JS, Duan F, Sicks J, Rakowski B, Diefenbach M, Rigotti N. Risk perceptions among National Lung Screening Trial participants at one-year follow-up. In press, Cancer. (IN PRESS)
  • NLST Baseline Screening Results Paper writing team. The National Lung Screening Trial: Baseline Screening Results (In Press NEJM) (IN PRESS)
  • Gareen IF, Sicks J, Adams A, Moline D,Coffman-Kadish N,Aberle DR, Identifying and collecting pertinent medical records for centralized abstraction in a multi-center randomized clinical trial: The model used by the American College of Radiology arm of the National Lung Screening Trial. Contemp Clin Trials. 2013 Jan;34(1):36-44. doi: 10.1016/j.cct.2012.09.002. Epub 2012 Sep 11. (2013)
  • Hillner BE, Siegel BA, Hanna L, Shields AF, Duan F, Gareen IF, Quinn B,Coleman RE. Impact of 18F-FDG PET Used After Initial Treatment of Cancer:Comparison of the National Oncologic PET Registry 2006 and 2009 Cohorts. J NuclMed. 2012 May;53(5):831-7. Epub 2012 Mar 23. PubMed PMID: 22448033. (2012)
  • Vanness DJ, Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, Gareen IF, Herman BA, Kuntz KM, Zauber AG, van Ballegooijen M, Feuer EJ, Chen MH, Johnson CD. Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations. Radiology. 2011 Nov;261(2):487-98. Epub 2011 Aug 3. PubMed PMID: 21813740; PubMed Central PMCID: PMC3198218. (2012)
  • Marcus PM, Gareen IF, Miller AB, Rosenbaum J, Keating K, Aberle DR, Berg CD. The National Lung Screening Trial's Endpoint Verification Process: determining the cause of death. Contemp Clin Trials. 2011 Nov;32(6):834-40. Epub 2011 Jul 18. PubMed PMID: 21782037; PubMed Central PMCID: PMC3185147. (2011)
  • National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011 Aug 4;365(5):395-409. Epub 2011 Jun 29. PubMed PMID: 21714641. (2011)
  • Hillner BE, Siegel BA, Shields AF, Duan F, Gareen IF, Hanna L, Coleman RE.Impact of Dedicated Brain PET on Intended Patient Management in Participants of the National Oncologic PET Registry. Mol Imaging Biol. 2011 Feb;13(1):161-5. PubMed PMID: 21080232. (2011)
  • National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen IF, Lynch DA, Marcus PM, Pinsky PF. Baseline Characteristics of Participants in the Randomized National Lung Screening Trial. J Natl Cancer Inst. 2010 Dec 1;102(23):1771-9. Epub 2010 Nov 22.PMID: 21119104. (2010)